By allowing ads to appear on this site, you support the local businesses who, in turn, support great journalism.
Takeda earns FDA approval
Local plant gets government OK for second product
5c38ff24f25ad.image.jpg
The Shire manufacturing facility at Stanton Springs near Social Circle is where products made from plasma are made to help patients with immune disorders. The plant is now owned by Takeda after a $60 billion-plus deal that was completed Tuesday, Jan. 8, 2019. - photo by Submitted Photo

SOCIAL CIRCLE, Ga. — Takeda Pharmaceutical Co. has earned federal approval for a second product made at its Stanton Springs facility in Walton County.

The company announced Monday morning the U.S. Food and Drug Administration approved production of Flexbumin 25%, which is indicated for burns, cardiopulmonary bypass surgery and hemolytic disease of the newborn.

“This latest approval is a significant milestone for the Georgia facility, Takeda and our patients,” Thomas Wozniewski, the company’s global manufacturing and supply officer, said in a statement.

“This new state-of-the-art facility is providing much needed additional capacity for meeting increasing global demand for plasma-derived therapies, and our team there will continue to scale up production over the coming years.”

Takeda has more than 1,000 full-time and contract employees at Stanton Springs.